Osnovum

We improve skeletal health to extend lifespan and increase quality of life

Print
Claim My Business
Form C
View on Wefunder
Security Type
Preferred Stock
Categories
Technology, Other, Financial Services, Healthcare & Medical, Retail
Min Investment
$100
Location
Henderson, NV
Offering Date
November 17, 2020
Expected Close Date
April 30, 2025
Target Raise
$50.00K-$124.00K
No. Investors
68
Security Price
$40
Deal Notes

Price per Share: $25.00

Valuation
$14,400,000
Website
osnovum.com
Number of Employees
4
Cash
$137
Revenue
$5
Short Term Debt
$4,643
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-22,650

Company Description

OsNovum has developed the technology to regenerate bone to maintain skeletal health. Weak bones are a major reason for frailty as we age. OsNovum has the proven technology to regenerate bone but will also open clinics devoted exclusively to skeletal heath and the prevention of frailty as we age.   

In one year, we hope to introduce our technology to medicine for bone regeneration and open the initial clinics devoted to skeletal health.  After two years, we hope to show significant revenue growth and plan a public offering to expand OsNovum clinics worldwide. In 5 years, we hope that OsNovum will be recognized as the world leader in maintaining skeletal health with treatment facilities worldwide. These are forward looking projections and are not guaranteed.

Given the Company’s limited operating history, the Company cannot reliably estimate how much revenue it will receive in the future, if any.

Perks

Invest $250+ for Personal invitation to Quarterly investor Zoom Meeting update
$500+ One free skeletal health evaluation for you or someone you choose.
$1,000+ Two free skeletal health evaluations for you or someone you choose
$10,000+ Two free OsNovum regenerative applications for you or someone you choose
Invest $250+ for Personal invitation to Quarterly investor Zoom Meeting update
$500+ One free skeletal health evaluation for you or someone you choose.
$1,000+ Two free skeletal health evaluations for you or someone you choose
$10,000+ Two free OsNovum regenerative applications for you or someone you choose

Key Deal Facts

OsNovum founders own the patent to this technology
Already FDA-cleared for maxillofacial use, streamlining the track to clearance in the skeleton
Disruptive new technology for the $73B osteoporosis treatment industry
Parent company, SteinerBio, world leader in bone regeneration provides building and staff
We have a clear exit strategy in place at 3 years
Launch of specialty clinics using our tech, guided by world leading scientists, staffed by industry leading clinicians
Profits will be generated by our regenerative technology, but accelerated through the OsNovum clinics

Use of Proceeds

$60,750 

  • 92.5% FDA Tests
  • 7.5% Wefunder fees

$1,070,000

  • 15% FDA Tests
  • 2.5% ISO Certification
  • 10% Regulatory Submission
  • 10% Legal, accounting, Funding Acquisition
  • 15% Capitol Improvements
  • 10% Production Equipment
  • 10% Product Delivery System
  • 20% Salaries
  • 7.5% Wefunder fees

Management Team / Advisory Board Bios

Gregory Steiner
CEO SteinerBio and OsNovum
Discovered and patented the molecule that stimulates bone growth

Roslynn L Steiner
President SteinerBio and OsNovum
Guided and executed plans for the growth of SteinerBio into a world leading maxillofacial bone graft company

Daniel Vargas
VP Marketing
Developed, planned, and executed the strategy for making SteinerBio a world leading biotechnology company

Deal Notes

Price per Share: $25.00

Amount Raised : $85,152
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment